EXPERRT is Expertise in Review of Rare Treatments, and what the legislation will do is ensure Medicaid access decisions with regard to medicines for rare diseases and precision medicines are made in consultation with experts. iBIO provided written testimony in support for HB2259.

Click Here to read iBIO’s Testimony